Hyperhomocysteinemia and coronary artery disease in Pakistan

M Perwaiz Iqbal1

  • 1Department of Biological and Biomedical Sciences, Aga Khan University Hospital, Karachi.

Insights

Coronary artery disease (CAD) risk in Pakistani men is high, especially in younger individuals. Mild hyperhomocysteinemia is common but not directly linked to CAD, with nutrient deficiencies being a likely cause.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Epidemiology
  • Population Health

Background:

  • Coronary artery disease (CAD) poses a significant health burden, particularly in Pakistani men at younger ages.
  • The lower-middle socioeconomic strata are disproportionately affected by CAD.
  • Mild hyperhomocysteinemia is prevalent in the Pakistani population, affecting both patients with acute myocardial infarction (AMI) and healthy individuals.

Purpose of the Study:

  • To investigate the association between hyperhomocysteinemia and CAD in the Pakistani population.
  • To explore the role of methylenetetrahydrofolate reductase (MTHFR) 677C>T mutation in CAD risk.
  • To identify the underlying causes of hyperhomocysteinemia in this demographic.

Main Methods:

  • Observational study design.
  • Measurement of plasma homocysteine levels.
  • Assessment of MTHFR 677C>T mutation status.
  • Evaluation of folate, vitamin B6, and vitamin B12 levels.

Main Results:

  • No significant association was found between hyperhomocysteinemia and CAD in Pakistani individuals.
  • The MTHFR 677C>T mutation did not show evidence of association with CAD.
  • A high prevalence of folate and vitamin B6 deficiency was identified as a major contributor to hyperhomocysteinemia.

Conclusions:

  • Mild hyperhomocysteinemia is common in Pakistan but not a direct risk factor for CAD in this population.
  • Micronutrient deficiencies, particularly folate and vitamin B6, are key drivers of hyperhomocysteinemia.
  • Combined deficiencies and mild hyperhomocysteinemia may synergistically interact with classical risk factors to elevate CAD risk.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...